New research has uncovered a critical mechanism that allows rotavirus to infect human cells, providing fresh insights into potential treatments for this pervasive virus. Despite the availability of vaccines, rotavirus continues to pose a serious risk, particularly to infants and young children, resulting in over 128,500 deaths annually around the world. While particularly common in developing countries, the decline in vaccination rates in the United States has led to a concerning increase in cases.
The findings, published in PNAS, highlight the work of a research team led by Siyuan Ding, an associate professor of molecular microbiology at Washington University School of Medicine. “Rotavirus kills infants and children, young people who never had a chance at life,” Ding said. “That’s why we want to develop effective therapeutics, even though we already have vaccines. Not all children receive the vaccine, and this virus is highly infectious. Currently, we can only manage the symptoms once a child is infected.”
To explore possible treatments, Ding and his colleagues investigated the body’s cellular characteristics that could be harnessed to fend off viral infections. This approach holds promise for multiple diseases, as it targets common pathways rather than focusing solely on the virus itself, potentially minimizing the development of drug resistance.
The study revealed that when a rotavirus particle penetrates a cell, it does not immediately replicate. Instead, it resides in a small compartment known as an endosome. The researchers identified an enzyme called fatty acid 2-hydroxylase (FA2H) that is crucial for the virus to escape from endosomes and initiate infection. By employing advanced gene-editing techniques, the team demonstrated that removing the FA2H gene from human cells effectively trapped the virus in endosomes, preventing successful reproduction and infection.
To validate these findings in a living organism, the researchers created genetically modified mice that lacked the FA2H enzyme in their small intestine cells. These mice displayed significantly fewer symptoms upon being infected with rotavirus compared to their non-modified counterparts, underscoring the enzyme’s vital role in the infection process.
Ding pointed out that this approach is distinct from traditional vaccines, which typically stimulate the body to produce antibodies preventing pathogens from entering cells. By disabling FA2H, the research intervenes in the infection process, empowering the body’s natural defenses against rotavirus and similar pathogens. “Viruses are dependent on hosts, so we’re preventing infection by stopping them from using the host’s machinery,” Ding explained.
Interestingly, the study found that the mechanism involving FA2H may also be relevant for other infectious agents, such as the Junín virus and Shiga toxin, indicating a shared ‘entry code’ among various pathogens. With this knowledge, Ding and his team can now pursue the development of drugs that mimic the effects of FA2H gene editing.
This pioneering research was supported by the NIH, with the authors solely responsible for the content, which does not reflect the official views of the agency. As the fight against rotavirus continues, these insights could lay the groundwork for new therapeutic options and a broader understanding of how to combat viral infections.
Tags: Rotavirus, Viral Infection, Healthcare Research, Washington University, Siyuan Ding, FA2H, Infant Health, Vaccination, Therapeutic Development
Categories: Health, Medical Research, Infectious Diseases
Original Source: https://www.futurity.org/rotavirus-infection-3300842/
Category :
Tags:
Publish Date: 2025-10-20 22:14:00
